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Measurement of total antioxidant response in
colorectal cancer using a novel automated method
Aim: The aim of this study was to compare the antioxidative status in patients with colorectal cancer
and healthy controls, based on measurements made using a novel method.
Materials and Methods: The study was conducted between 2005 and 2007, and included 30 patients
with colorectal cancer and 30 healthy controls. To determine the antioxidative status of the patients
and healthy controls, serum total antioxidant capacity was measured using a novel automated
method. Blood samples were taken from the healthy controls and the patients.
Results: Total serum antioxidant capacity was significantly lower in colorectal cancer patients than
in healthy persons (P < 0.023).
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Conclusions: Patients with colorectal cancer are exposed to oxidative stress, which may have a role
in the pathogenesis of the disease. The novel automated method used in this study was developed in
our laboratory, and is feasible and fully automated; therefore, it may be useful for evaluating oxidativeantioxidative balance in patients with colorectal cancer.
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Kolorektal kanserli hastalarda total antioksidan yanıtın yeni bir
metodla incelenmesi
Amaç: Bu çalışmanın amacı, kolorektal kanserli hastalar ile sağlıklı grup arasında yeni bir metotla
anti-oksidatif durumu değerlendirmektir.
Yöntem ve Gereç: 2005 ile 2007 yılları arasında, 30 kolorektal kanserli hasta ile 30 sağlıklı birey
çalışmaya dahil edildi. Hasta ve sağlıklı bireylerin anti-oksidatif durumları yeni bir metod
kullanılarak ölçüldü. Hasta ve kontrol grubundan kan örnekleri alındı.
Bulgular: Total antioksidan kapasite, kolorektal kanserli hastalarda sağlıklı kişilere göre istatiksel
olarak anlamlı derecede düşük idi (P < 0.023).
Sonuç: Kolorektal kanser hastaları, hastalığın patogenezinde rol oynayan oksidatif strese maruz
kalmaktadır. Bu yeni metod ile, total anti-oksidan kapasitenin değerlendirilmesi mümkündür ve tam
otomatiktir. Bu nedenle, kolorektal kanserli hastalarda oksidatif-anti-oksidatif dengenin
değerlendirilmesinde kullanışlıdır.
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Colorectal cancer is one of the most common neoplastic diseases in humans. In
all, 50% of the Western population develops a colorectal cancer by the age of 70,
and in about 1 in 10 of these individuals. There are many factors related to reactive
oxygen species (ROS) and free radicals involved in the initiation and progression
of cancer (1). The role of oxidative stress in the pathogenesis and development of
human colorectal cancer has been suggested in various reports. The
gastrointestinal tract is particularly susceptible to attack by reactive oxygen species,
which leads to carcinogenesis. Antioxidants play an important role in the defense
against reactive oxygen species (2); however, information on biochemical
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alterations in tissue and blood, in particular
antioxidative status, and their correlation with clinical
staging of the disease is lacking (1,3).
A recent study reported that oxidative stress is a
risk factor for colorectal carcinogenesis. In
inflammatory reactions activated leucocytes produce
mutagenic and mitogenic free radicals, thereby
promoting tumor formation (4). It is known that ROS
are formed in excess in chronic diseases of the
gastrointestinal tract (5), but the precise mechanisms
of oxidative stress induced in cancer cells and the role
of ROS in colorectal cancer progression are not
precisely known (6). Changes in some parameters of
the oxidative-antioxidative system in colorectal cancer
were reported in earlier studies (5,6). The oxidative
effects of ROS are controlled by exogenous
antioxidants such as vitamins E and C, and by
endogenous antioxidants such as scavenger enzymes
(i.e. superoxide dismutase and glutathione
peroxidase), bilirubin, and uric acid. Under some
conditions, increases in oxidants and decreases in
antioxidants cannot be prevented, and the
oxidative/antioxidative balance shifts towards an
oxidative status (7).
Antioxidant activity is known to reflect the altered
redox balance of affected fluids, tissues, or organs in
several pathologic states (8,9). Plasma is an important
vehicle that can either protect against oxidative
damage to different blood components or distribute
dietary antioxidants to the remainder of the body.
Plasma concentrations of antioxidants can be
measured separately in the laboratory, but these
measurements are time-consuming, labor-intensive,
and costly. As the antioxidative effects of antioxidant
components in plasma are additive, measurement of
total antioxidant response (TAR) reflects the
antioxidative status of plasma (10). In the present
study we measured and evaluated total antioxidative
status in colorectal cancer patients using a recently
developed measurement method (7).
Materials and methods
Subjects
The study was conducted at the Harran University
Medical Faculty, Department of General Surgery and
Department of Clinical Biochemistry. The study
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population, treated in our hospital, consisted of 30
patients with colorectal cancer and 30 healthy control
volunteers. All patients and volunteers gave informed
consent to participate in the study, which was
approved by the local ethics committee. Patient and
control demographic data were not statistically
different (P > 0.05) (Table 1).
The study included 30 patients with clinical stage
III primary colorectal cancer. Patients with stage IV
cancer were excluded from the study. The diagnosis
of colorectal cancer was made based on physical
examination, histopathological evaluation, routine
clinical biochemical parameters, and abdominal
ultrasound and tomography findings. Conventional
histopathological parameters, such as AJCC/UICC
TNM stage, tumor type, and grade of differentiation,
were evaluated by our experienced pathologist.
Differentiation and histological cancer type were
evaluated according to World Health Organization
(WHO) guidelines (11).
Blood samples
Blood samples were collected from the patients
and controls into tubes containing EDTA after
overnight fasting. Plasma was separated from cells via
centrifugation at 1500 g for 10 min. The samples were
stored at −80 °C until use.
Measurement of plasma total antioxidative
status
Plasma total antioxidative status (TAS) was
measured using a novel automated colorimetric
version of the total antioxidant response (TAR)
method (7). With this method the hydroxyl radical,
the most potent biological radical, is produced by the
Fenton reaction and reacts with the colorless substrate
o-dianisidine to produce the dansyl radical, which is
bright yellowish brown. Upon addition of a plasma
sample, the oxidative reactions initiated by the
hydroxyl radicals present in the reaction medium are
suppressed by the antioxidant components of the
plasma, preventing color change and, thereby,
providing an effective measure of the total
antioxidative status of plasma. The assay results are
expressed as mol Trolox Eq/L, and the precision of
this assay is excellent, the variation being less than 3%
(TAS).
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Discussion

Statistical analysis
All data are expressed as mean ± standard
deviation (SD). The significance of difference was
determined using parametric statistical methods. The
Student’s t-test was used for pair-wise comparisons.
Statistical significance was defined as P < 0.05. Data
were analyzed using SPSS v.11.0 for Windows (SPSS
Inc., Chicago, IL, USA).
Ethical issues
This study was performed according to
institutional guidelines for clinical research with
human volunteers, and according to national and
international regulations under the supervision of a
bioethics consultant.
Results
Participant demographic data are presented in
Table 1. There were no statistically differences in age,
sex, or body mass index (BMI) between the patients
and healthy controls (P > 0.05).
Measurement of the antioxidative system matched
the analyzed clinical features of colorectal cancer in a
statistically significant manner. There were significant
differences between the patients and controls
regarding plasma TAS level (Table 2). The capacity of
the antioxidative system decreased (P < 0.023) as
colorectal cancer progressed.

Table 1. Patient and control demographic data.
Parameters

Controls
(n = 30)

Patients
(n = 30)

Age (years)

49 ± 12

51 ± 13ns

Sex (female/male)
Body mass index (kg/m2)

14/16

17/13

22.5 ± 3.8

23.8 ± 2.1n

Values are mean ± SD. nsNot significant.
Table 2. Patient and control antioxidative status (TAS).
TAS
(mmol Trolox Eq/L)

Values are mean ± SD.

August 2009

Controls
(n = 30)

Patients
(n = 30)

P

1.59 ± 1.13

0.62 ± 1

< 0.023

It is well known that formation of ROS is a normal
consequence of a variety of essential biochemical
reactions. It is also known that oxygen radicals could
be formed in excess in chronic diseases of the
gastrointestinal tract (5). The main source of oxidants
in the gut is probably phagocytes, which accumulate
in the mucus of patients with bowel disease and could
generate oxidants upon activation, and potentially
contribute to an increased risk of cancer (12).
Therefore, an adequate range of antioxidative defense
within and outside cells has also been considered very
important in protecting against oxidative damage to
cell components, including membrane phospholipids,
proteins, and DNA (13,14). Malondialdehyde is
elevated in colon cancer patients, which is most
probably associated with oxidative reactions and
tissue damage involved in the pathology of colon
cancer (15).
Multiple factors are involved in the etiology of
colorectal cancer, just as multiple steps are implicated
in its pathogenesis. It is most probable that both
environmental and constitutional factors are
interwoven, but the process varies from one
individual to another. Thus, neither one factor nor
one set of factors will underlie the etiology in all cases
of colorectal carcinoma, as reported by Aksoy and
Akinci (16). Free radicals and lipid peroxides are
considered to be very important in carcinogenesis
(12,14). Colorectal tissue is constantly exposed to a
variety of hazardous chemicals that may be potential
carcinogens, such as drugs, food additives, and food
constituents; therefore, free radicals formed during
the metabolic activation of these compounds are
considered an important factor in carcinogenesis
(10,12,14,17). Indeed, some investigators have
reported elevated lipid peroxidation in experimental
(11) and human colorectal cancer (18,19,20).
Plasma contains various antioxidant molecules;
proteins, particularly albumin, constitute the main
antioxidant component of serum. Free sulfhydryl
groups of proteins are mainly responsible for
antioxidant response. Others are uric acid and
bilirubin, which serve as potent antioxidants via
radical scavenging and reducing activities. Because
the effects of the antioxidant components in plasma
are additive, measurement of total antioxidative
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response accurately reflects the redox status of plasma.
All of these antioxidants were measured as TAS using
a novel method (7) in the present study and were
significantly lower in the colorectal cancer patients
than in the healthy controls. This method provided
useful measurement for the rapid evaluation of total
antioxidant capacity (TAC), a parameter valuable not
only in the diagnosis of colorectal cancer, but also for
other disorders involving oxidative stress. In terms of
colorectal cancer, routine measurement of TAC may
be a useful aid in the assessment of oxidative stress
status, and in the determination of an appropriate
treatment plan. Routine screening of TAC in
colorectal cancer patients may also prove useful for
early recognition of colorectal cancer oxidative stress.
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In conclusion, our findings suggest that some
components of antioxidative status are deficient and
oxidative injury occurs in patients with colorectal
cancer. We determined that colorectal cancer patients
had lower TAC levels than healthy controls. It may be
inferred that the patients were exposed to oxidative
stress and consumed significant amounts of plasma
antioxidants, which may have played a role in the
etiopathogenesis of the disease. The novel assay used
in this study is rapid, easy, stable, reliable, sensitive,
inexpensive, and fully automated; therefore, it may be
useful in evaluating oxidative-antioxidative balance
in patients and may be useful for other measurements,
such as antioxidant supplementation, and can
increase the effectiveness of treatment.
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